Advanced aging skin and itch: Addressing an unmet need

Dermatologic Therapy

Volumn 26, Issue 2, 2013, Pages 92-103

  Garibyan, Lilit ^a   Chiou, Albert S ^a   Elmariah, Sarina B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

elderly; pruritus; Willan's itch; xerosis

Indexed keywords

ARTICLE; CUTANEOUS PARAMETERS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ELDERLY CARE; PATHOGENESIS; PREVALENCE; PRURITUS; QUALITY OF LIFE; XEROSIS;

AGE FACTORS; AGED; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFLAMMATION; PRURITUS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SKIN AGING; SKIN DISEASES;

EID: 84875862495     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12029     Document Type: Article

References (73)

1. Yalcin B, Tamer E, Toy GG, Oztas P, Hayran M, Alli N,. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol 2006: 45 (6): 672-676.
2. Tran B, Curtis AR, Lee AD, Yosipovitch G,. Acquired eruptive vellus hair cysts. Int J Dermatol 2011: 50 (8): 1032-1033.
3. Beauregard S, Gilchrest BA,. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987: 123 (12): 1638-1643.
4. Scribner MD,. Propranolol therapy. Arch Dermatol 1977: 113 (9): 1303.
5. Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC,. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 2011: 147 (10): 1153-1156.
6. Zachariae R, Lei U, Haedersdal M, Zachariae C,. Itch severity and quality of life in patients with pruritus: preliminary validity of a danish adaptation of the itch severity scale. Acta Derm Venereol 2011: 92 (5): 508-514.
7. Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006: 21 (12): 3495-3505.
8. Fleischer AB, Jr,. Pruritus in the elderly: management by senior dermatologists. J Am Acad Dermatol 1993: 28 (4): 603-609.
9. Smith DR, Guo YL, Lee YL, Hsieh FS, Chang SJ, Sheu HM,. Prevalence of skin disease among nursing home staff in southern Taiwan. Ind Health 2002: 40 (1): 54-58.
10. Curtis AR, Yosipovitch G,. Erythrodermic verrucous psoriasis. J Dermatolog Treat 2012: 23 (3): 215-218.
11. Pochi PE, Strauss JS, Downing DT,. Age-related changes in sebaceous gland activity. J Invest Dermatol 1979: 73 (1): 108-111.
12. Smith L,. Histopathologic characteristics and ultrastructure of aging skin. Cutis 1989: 43 (5): 414-424.
13. Waller JM, Maibach HI,. Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure. Skin Res Technol 2006: 12 (3): 145-154.
14. Li J, Tang H, Hu X, Chen M, Xie H,. Aquaporin-3 gene and protein expression in sun-protected human skin decreases with skin ageing. Australas J Dermatol 2010: 51 (2): 106-112.
15. Rogers J, Harding C, Mayo A, Banks J, Rawlings A,. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 1996: 288 (12): 765-770.
16. Conti A, Rogers J, Verdejo P, Harding CR, Rawlings AV,. Seasonal influences on stratum corneum ceramide 1 fatty acids and the influence of topical essential fatty acids. Int J Cosmet Sci 1996: 18 (1): 1-12.
17. Choi EH, Man MQ, Xu P,. Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol 2007: 127 (12): 2847-2856.
18. Jensen JM, Forl M, Winoto-Morbach S., Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Exp Dermatol 2005: 14 (8): 609-618.
19. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM,. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 1995: 95 (5): 2281-2290.
20. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM,. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003: 121 (2): 345-353.
21. Oaklander AL,. Neuropathic pruritus following Wallenberg syndrome. Neurology 2009: 73 (19): 1605; author reply 1605-1606.
22. Patel T, Yosipovitch G,. The management of chronic pruritus in the elderly. Skin Therapy Lett 2010: 15 (8): 5-9.
23. Ward JR, Bernhard JD,. Willan's itch and other causes of pruritus in the elderly. Int J Dermatol 2005: 44 (4): 267-273.
24. Steckelings UM, Artuc M, Wollschlager T, Wiehstutz S, Henz BM,. Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol 2001: 81 (5): 321-325.
25. Reich A, Szepietowski JC,. Opioid-induced pruritus: an update. Clin Exp Dermatol 2010: 35 (1): 2-6.
26. Krasovec M, Elsner P, Burg G,. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology 1993: 186 (4): 248-252.
27. Joly P, Benoit-Corven C, Baricault S, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study. J Invest Dermatol 2007: 127 (12): 2766-2771.
28. Cassano N, Tessari G, Vena GA, Girolomoni G,. Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy. Am J Clin Dermatol 2010: 11 (6): 399-411.
29. Wang H, Yosipovitch G,. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010: 49 (1): 1-11.
30. Berger TG, Steinhoff M,. Pruritus and renal failure. Semin Cutan Med Surg 2011: 30 (2): 99-100.
31. Bergasa NV,. The itch of liver disease. Semin Cutan Med Surg 2011: 30 (2): 93-98.
32. Lewiecki EM, Rahman F,. Pruritus. A manifestation of iron deficiency. JAMA 1976: 236 (20): 2319-2320.
33. Lonsdale-Eccles A, Carmichael AJ,. Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies. Drugs Aging 2003: 20 (3): 197-208.
34. Chiang HC, Huang V, Cornelius LA,. Cancer and itch. Semin Cutan Med Surg 2011: 30 (2): 107-112.
35. Norman RA,. Xerosis and pruritus in the elderly: recognition and management. Dermatol Ther 2003: 16 (3): 254-259.
36. White-Chu EF, Reddy M,. Dry skin in the elderly: complexities of a common problem. Clin Dermatol 2011: 29 (1): 37-42.
37. Patel TS, Freedman BI, Yosipovitch G,. An update on pruritus associated with CKD. Am J Kidney Dis 2007: 50 (1): 11-20.
38. Raksha MP, Marfatia YS,. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008: 74 (1): 80.
39. Mistik S, Utas S, Ferahbas A, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol 2006: 20 (6): 672-678.
40. Curtis AR, Oaklander AL, Johnson A, Yosipovitch G,. Trigeminal trophic syndrome from stroke: an under-recognized central neuropathic itch syndrome. Am J Clin Dermatol 2012: 13 (2): 125-128.
41. Hong J, Buddenkotte J, Berger TG, Steinhoff M,. Management of itch in atopic dermatitis. Semin Cutan Med Surg 2011: 30 (2): 71-86.
42. Reich A, Stander S, Szepietowski JC,. Drug-induced pruritus: a review. Acta Derm Venereol 2009: 89 (3): 236-244.
43. Wallengren J, Tegner E, Sundler F,. Cutaneous sensory nerve fibers are decreased in number after peripheral and central nerve damage. J Am Acad Dermatol 2002: 46 (2): 215-217.
44. Berger TG, Steinhoff M,. Pruritus in elderly patients-eruptions of senescence. Semin Cutan Med Surg 2011: 30 (2): 113-117.
45. Savk O, Savk E,. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol 2005: 52 (6): 1085-1087.
46. Goodkin R, Wingard E, Bernhard JD,. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic [corrected] pruritus. J Am Acad Dermatol 2003: 48 (4): 521-524.
47. Scribner M,. Diabetes and pruritus of the scalp. JAMA 1977: 237 (15): 1559.
48. Bin Saif GA, Ericson ME, Yosipovitch G,. The itchy scalp-scratching for an explanation. Exp Dermatol 2011: 20 (12): 959-968.
49. Yamaoka H, Sasaki H, Yamasaki H, et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care 2010: 33 (1): 150-155.
50. Seo WK, Kwon DY, Seo SH, Park MH, Park KW,. Neuropathic pruritus following Wallenberg syndrome. Neurology 2009: 72 (7): 676.
51. Kimyai-Asadi A, et al. Poststroke pruritus. Stroke 1999: 30 (3): 692-693.
52. Rashid RM, Khachemoune A,. Trigeminal trophic syndrome. J Eur Acad Dermatol Venereol 2007: 21 (6): 725-731.
53. Bouvresse S, Chosidow O,. Scabies in healthcare settings. Curr Opin Infect Dis 2010: 23 (2): 111-118.
54. Berger TG, Steinhoff M,. Pruritus/itch: the science and treatment. Introduction. Semin Cutan Med Surg 2011: 30 (2): 63.
55. Irizarry E, Brownell I, Pomeranz MK,. The "louse blouse" as a cause of erythroderma. Arch Dermatol 2007: 143 (5): 682.
56. Pacan P, Grzesiak M, Reich A, Szepietowski JC,. Is pruritus in depression a rare phenomenon? Acta Derm Venereol 2009: 89 (1): 109-110.
57. Parsons JM,. Transient acantholytic dermatosis (Grover's disease): a global perspective. J Am Acad Dermatol 1996: 35 (5 Pt 1): 653-666; quiz 667-670.
58. Scheinfeld N, Mones J,. Seasonal variation of transient acantholytic dyskeratosis (Grover's disease). J Am Acad Dermatol 2006: 55 (2): 263-268.
59. Hashimoto K, Moiin A, Chang MW, Tada J,. Sudoriferous acrosyringeal acantholytic disease. A subset of Grover's disease. J Cutan Pathol 1996: 23 (2): 151-164.
60. Yosipovitch G, Samuel LS,. Neuropathic and psychogenic itch. Dermatol Ther 2008: 21 (1): 32-41.
61. van Os-Medendorp H, Ros WJ, Eland-de Kok PC, et al. Effectiveness of the nursing programme "Coping with itch": a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol 2007: 156 (6): 1235-1244.
62. Rawlings AV, Canestrari DA, Dobkowski B,. Moisturizer technology versus clinical performance. Dermatol Ther 2004: 17 (Suppl 1): 49-56.
63. Rivard J, Lim HW,. Ultraviolet phototherapy for pruritus. Dermatol Ther 2005: 18 (4): 344-354.
64. O'Donoghue M, Tharp MD,. Antihistamines and their role as antipruritics. Dermatol Ther 2005: 18 (4): 333-340.
65. Greaves MW,. Itch in systemic disease: therapeutic options. Dermatol Ther 2005: 18 (4): 323-327.
66. Bergasa NV, McGee M, Ginsburg IH, Engler D., Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology 2006: 44 (5): 1317-1323.
67. Ehrchen J, Stander S,. Pregabalin in the treatment of chronic pruritus. J Am Acad Dermatol 2008: 58 (2 Suppl): S36-S37.
68. Naini AE, Harandi AA, Khanbabapour S, Shahidi S, Seirafiyan S, Mohseni M,. Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi J Kidney Dis Transplant 2007: 18 (3): 378-381.
69. Razeghi E, Eskandari D, Ganji MR, Meysamie AP, Togha M, Khashayar P,. Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail 2009: 31 (2): 85-90.
70. Solak Y, Biyik Z, Atalay H, et al. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance hemodialysis patients: a prospective crossover study. Nephrology 2012: 17 (8): 710-717.
71. Stander S, Bockenholt B, Schurmeyer-Horst F, et al. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol 2009: 89 (1): 45-51.
72. Zylicz Z, Krajnik M, Sorge AA, Costantini M,. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003: 26 (6): 1105-1112.
73. Saini KS, Patnaik MM, Tefferi A,. Polycythemia vera-associated pruritus and its management. Eur J Clin Invest 2010: 40 (9): 828-834.